The 91 rating InvestorsObserver gives to Organogenesis Holdings Inc (ORGO) stock puts it near the top of the Healthcare sector.
In addition to scoring higher than 99 percent of stocks in the Healthcare sector, ORGO’s 91 overall rating means the stock scores better than 91 of all stocks.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.
These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Organogenesis Holdings Inc Stock Today?
Organogenesis Holdings Inc (ORGO) stock is trading at $18.70 as of 10:43 AM on Thursday, May 13, a rise of $1.52, or 8.85% from the previous closing price of $17.18. The stock has traded between $17.36 and $18.94 so far today. Volume today is below average. So far 122,243 shares have traded compared to average volume of 789,460 shares.
Click Here to get the full Stock Score Report on Organogenesis Holdings Inc (ORGO) Stock.
